| Title |
PD-1 and PD-L1 antibodies in cancer: current status and future directions
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, February 2017
|
| DOI | 10.1007/s00262-017-1954-6 |
| Pubmed ID | |
| Authors |
Arjun Vasant Balar, Jeffrey S. Weber |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 11% |
| Greece | 1 | 11% |
| Comoros | 1 | 11% |
| Spain | 1 | 11% |
| Mexico | 1 | 11% |
| Unknown | 4 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 78% |
| Scientists | 1 | 11% |
| Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 203 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 202 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 36 | 18% |
| Researcher | 31 | 15% |
| Student > Master | 30 | 15% |
| Student > Bachelor | 26 | 13% |
| Student > Doctoral Student | 13 | 6% |
| Other | 29 | 14% |
| Unknown | 38 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 29% |
| Biochemistry, Genetics and Molecular Biology | 33 | 16% |
| Immunology and Microbiology | 18 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 6% |
| Agricultural and Biological Sciences | 12 | 6% |
| Other | 23 | 11% |
| Unknown | 45 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2022.
All research outputs
#3,195,793
of 26,017,215 outputs
Outputs from Cancer Immunology, Immunotherapy
#225
of 3,029 outputs
Outputs of similar age
#55,783
of 326,699 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#8
of 39 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,699 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.